Bernales, Maylin B.
HRN: 21-65-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2022
CEFUROXIME 1.5GM (VIAL)
08/01/2022
08/02/2022
IV
1.5g
Q8hours X 3 Doses
S/P CS
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes